Replies to post #1 on Axonyx Inc (AXYX)

[trade1]

The current medical treatments for Alzheimers only help to delay or prevent symptoms from becoming worse for a limited time and may help control some behavioral symptoms. Phenserine has been shown to have two mechanisms of action: (1) the inhibition of the AChE enzyme, and (2) inhibition of the synthesis of A beta - a protein thought to be a potential cause of Alzheimer's disease and its progression. I just don't think the market has grasped the potential market for Phenserine.

Today's study of Posiphen showed the ability of transplanted human neuronal stem cells (HNSC) to differentiate into neurons in the brain area where they are needed. Posiphen could be used to treat an assortment of brain injuries in addition to Alzheimer's.

[MasterCMc]

I was holding axyx when their phase III clinical trials came back as duds a year and a half ago. that took the stock from 5 dollars to barely one, after being at 8 a month earlier (i bailed a week before the trial results came back). management kept providing positive outlooks for their new drug only to see it fail. Class action suits up the wazoo after that. I, for one, am very skeptical of anything management has to say. trust has gone out the window, take everything with a grain of salt.